Results 91 to 100 of about 137,868 (314)

Research Progress on the Association Between GLP-1 Receptor Agonists and Cardiomyopathy

open access: yesReviews in Cardiovascular Medicine
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a promising new class of drugs, whose clinical potential has recently been explored. Various preclinical studies and clinical trials initially demonstrated the efficacy of GLP-1RAs in treating type
Xiao Yang, Xinghui Li
doaj   +1 more source

Sodium‐glucose cotransporter 2 inhibitors and the risk of late onset epilepsy: A real‐world cohort study

open access: yesEpilepsia, EarlyView.
Abstract Objective Late onset epilepsy (LOE) is associated with substantial morbidity. Sodium‐glucose cotransporter 2 inhibitors (SGLT2i) may exert neuroprotective effects. This study evaluated the association between SGLT2i and risk of LOE among older adults with type 2 diabetes mellitus.
Bing‐Hua Lin   +3 more
wiley   +1 more source

Anthropometric and laboratory characteristics of healthy subjects, NAFLD, T2DM and NAFLD+T2DM.

open access: yes, 2015
Data are expressed as means ± standard error of the means (SEM).† One-way ANOVA;# Kruskal-WallisAnthropometric and laboratory characteristics of healthy subjects, NAFLD, T2DM and NAFLD+T2DM.
Parisa Shabani (701703)   +6 more
core   +1 more source

T2DM respondents characteristics and dyslipidemia prevalence.

open access: yes, 2021
T2DM respondents characteristics and dyslipidemia prevalence.
Md. Kamruzzaman (10918238)   +7 more
core   +1 more source

Post hoc test; Tukey’s HSD multiple comparisons of means of measured variables between T2DM & Malaria co-morbidity and T2DM only.

open access: yes, 2023
T2DM & Malaria Co-morbidity Group = participants who had both Type-2 diabetes mellitus and malaria infection, T2DM only = participants who had only Type-2 diabetes mellitus; Data represented Mean±SD. Mean difference was significant at α (DOCX)
Benjamin Aboagye (9360986)   +3 more
core   +1 more source

Genetics of T2DM in 2016: Biological and translational insights from T2DM genetics.

open access: yesNature reviews. Endocrinology, 2017
Type 2 diabetes mellitus (T2DM) is a major global health challenge. Development of more effective strategies for prevention and therapy depends on an improved understanding of its pathogenetic mechanisms. 2016 ends a period during which large-scale discovery of risk alleles for T2DM became routine and heralds a shift in research focus towards their ...
openaire   +2 more sources

Evaluating the perceptions of T2DM patients towards the risk and prevention of T2DM in their offspring / Anis Safura Ramli [PDF]

open access: yes, 2016
Offspring of T2DM patients have an increased risk of developing T2DM. One of the approaches to prevent their offspring from developing T2DM is to encourage T2DM patients to become the health promoter within the family.
Ramli, Anis Safura
core  

Prevalence of SCH in T2DM.

open access: yes, 2015
Prevalence of SCH in T2DM.
Cheng Han (87179)   +6 more
core   +1 more source

Perioperative Glycaemic Dynamics in Type 2 Diabetes Mellitus: Comparison of Minimally Invasive and Conventional Coronary Artery Bypass

open access: yesУкраїнський журнал серцево-судинної хірургії
Aim. To compare perioperative glycaemic dynamics and the need for inotropic support in patients with type 2 diabetes undergoing minimally invasive versus conventional coronary artery bypass grafting. Materials and Methods.
Ivan S. Dordiai   +2 more
doaj   +1 more source

Exploring the Socio‐Economic Toll of Non‐Communicable Diseases in Low‐Resource Settings: Novel Evidence From Mozambique

open access: yesThe International Journal of Health Planning and Management, EarlyView.
ABSTRACT Background The socio‐economic burden of increasingly prevalent non‐communicable diseases (NCDs) in low‐income countries is substantial and widely recognised. This study aimed to fill the remaining evidence gap for type 2 diabetes (T2DM) and hypertension (HTN) patients in selected health facilities across two provinces in Mozambique.
Maria Verykiou   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy